Skip to main content

Volume 16 Supplement 3

Sepsis 2012

Effect of Calotropis procera latex extracts on the hypothalamic TNFα and PGE2 levels in the rat model of yeast-induced pyrexia


Sepsis, a common cause of morbidity and mortality in critically ill patients, is associated with systemic inflammatory response syndrome due to upregulation of cyclooxygenase-2 and increase in the levels of PGE2. It is also associated with increase in the levels of proinflammatory cytokines like TNFα and IL-1β. Calotropis procera is a plant that grows in the wild producing latex. The aqueous and methanolic extracts of dried latex of this plant (AqDL and MeDL) and proteins isolated from the fresh latex (LP) have shown anti-inflammatory and anti-arthritic properties. AqDL and MeDL are orally effective, LP is effective parenterally. The current study was designed to evaluate the efficacy of these extracts against yeast-induced pyrexia and the levels of TNFα and PGE2 in the hypothalamus of rats.


Pyrexia was induced in rats by subcutaneous injection of yeast in the nape of the neck and the rectal temperature was measured at 0 hours (basal temperature), 3 hours and 6 hours. Rats were divided into groups (n = 6) and were treated with AqDL and MeDL given orally and LP given intravenously at 6 hours. Group I: NC (normal control); Group II: YC (yeast control); Group III: AqDL (200 mg/kg); Group IV: AqDL (400 mg/kg); Group V: MeDL (100 mg/kg); Group VI: MeDL (250 mg/kg); Group VII: LP (5 mg/kg); Group VIII: LP (25 mg/kg); Group IX: paracetamol (PCM 100 mg/kg). Rectal temperature was measured hourly until 9 hours. The levels of TNFα and PGE2 were measured in the excised hypothalamus region of the brain using ELISA kits.


Subcutaneous injection of yeast produced a marked increase in rectal temperature of rats with a maximum effect at 6 hours (101.17°C). Like paracetamol, treatment of rats with AqDL and MeDL produced a significant decrease in body temperature from 101.17°C at 6 hours to 97.9°C and 98.2°C at 9 hours respectively at higher doses and their effect was dose dependent while LP was found to be ineffective. The present study shows that treatment with yeast increased the tissue levels of TNFα (23.78 pg/mg) and PGE2 (66.48 pg/mg) as compared with the NC group (16.31 and 41.35 respectively). All of the fractions lowered the hypothalamic TNFα level while a marked reduction in PGE2 levels was observed with orally effective fractions, namely AqDL and MeDL.


Our results demonstrate that the orally administered fractions of latex of C. procera are effective in attenuating yeast-induced pyrexia and this effect is mediated through reduction in the levels of PGE2.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Guruprasad, B., Chaudhary, P. & Kumar, V. Effect of Calotropis procera latex extracts on the hypothalamic TNFα and PGE2 levels in the rat model of yeast-induced pyrexia. Crit Care 16 (Suppl 3), P45 (2012).

Download citation

  • Published:

  • DOI:


  • PGE2
  • Paracetamol
  • Methanolic Extract
  • Subcutaneous Injection
  • Systemic Inflammatory Response Syndrome